DekaBank Deutsche Girozentrale
KRRO icon

DekaBank Deutsche Girozentrale’s Korro Bio KRRO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$85K – 1404
2021
Q1 		$85K Hold
200
– – ﹤0.01% 1290
2020
Q4 		$354K Buy
+200
New +$264K ﹤0.01% 1095

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KRRO Position: Q2 2021 in Review

DekaBank Deutsche Girozentrale sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 200 shares — an estimated $85K sold.

DekaBank Deutsche Girozentrale first reported a position in KRRO in Q4 2020 and held it in 2 quarters. The position peaked at $354K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 200 Korro Bio shares in Q2 2021, an estimated $85K.
  • DekaBank Deutsche Girozentrale first reported a position in Korro Bio in Q4 2020 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Korro Bio position peaked at $354K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.